In Silico Screening. Hit Finding from Database Mining

The Practice of Medicinal Chemistry

Volumn , Issue , 2008, Pages 210-227

  Langer, Thierry ^a,c   Bryant, Sharon D ^b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c Inte:Ligand GmbH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349419169     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374194-3.00010-X     Document Type: Chapter

References (204)

1. Kubinyi H. Chance favors the prepared mind. From serendipity to rational drug design. J. Recept. Signal Transduct. Res. 1999, 19:15-39.
2. Lahana R. How many hits from HTS?. Drug Discov. Today 1999, 4:447-448.
3. Kubinyi H. The changing landscape in drug discovery. Compu-tational Approaches to Structure Based Drug Design 2007, 24-45. Royal Society of Chemistry, London. R.M. Stroud (Ed.).
4. Drews J. Drug discovery: a historical perspective. Science 2000, 287:1960-1964.
5. Brown F. Chemoinformatics: What is it and how does it impact drug discovery?. Annu. Rep. Med. Chem. 1998, 33:375-384.
6. Richie T. Chemoinformatics; manipulating chemical information to facilitate decision-making in drug discovery. Drug Discov. Today 2001, 6:813-814.
7. Johnson D.E., Blower P.E., Myatt G.J., Wolfgang G.H.I. Chem-tox informatics: data mining using a medicinal chemistry building block approach. Curr. Opin. Drug Discov. Dev. 2001, 4:92-101.
8. Oprea T.I., Gottfries J. Chemography: the art of navigating in chemical space. J. Combin. Chem. 2001, 3:157-166.
9. Oprea T.I. Chemical space navigation in lead discovery. Curr. Opin. Chem. Biol. 2002, 6:384-389.
10. Leach A.R., Gillet V.J. An Introduction to Chemoinformatics 2003, Kluwer Academic Publishers, Dordrecht, Netherlands.
11. Oprea T.I. Chemoinformatics in drug discovery. Methods and Principles in Medicinal Chemistry 2004, Vol. 23. Wiley-VCH, Weinheim. R. Mannhold, H. Kubinyi, G. Folkers (Eds.).
12. Kola I., Landis J. Can the pharmaceutical industry reduce attrition rates?. Nat. Rev. Drug Discov. 2004, 3:711-715.
13. Schuster D., Laggner C., Langer T. Why drugs fail - A study on side effects in new chemical entities. Curr. Pharmaceut. Des. 2005, 11:3545-3559.
14. Valler M.J., Green D. Diversity screening versus focused screening in drug discovery. Drug Discov. Today 2000, 5:286-293.
15. Van de Waterbeemd H. Which in vitro screens guide the prediction of oral absorption and volume of distribution?. Basic Clin. Pharmacol. Toxicol. 2005, 96:162-166.
16. Oprea T.I. Current trends in lead discovery: Are we looking for the appropriate properties?. J. Comput.-Aided Mol. Des. 2002, 16:325-334.
17. Langer T., Krovat E.-M. Chemical feature-based pharmacophores and virtual library screening for discovery of new leads. Curr. Opin. Drug Discov. Dev. 2003, 6:370-376.
18. Güner O., Clement O., Kurogi Y. Pharmacophore modeling and three dimensional database searching for drug design using catalyst: recent advances. Curr. Med. Chem. 2004, 11:2991-3005.
19. Fayyad U.M., Piatetsky-Shapiro G., Smyth P. From data mining to knowledge discovery. Advances in Knowledge Discovery and Data Mining 1996, 1-37. AAAI Press, Menlo Park, CA. U.M. Fayyad, G. Piatetsky-Shapiro, P. Smyth, R. Uthurusamy (Eds.).
20. Weininger D. SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. J. Chem. Inform. Comput. Sci. 1988, 28:31-36.
21. Weininger D., Weininger A., Weininger J.L. SMILES. 2. Algorithm for generation of unique SMILES notation. J. Chem. Inform. Comput. Sci. 1989, 29:97-101.
22. Wiswesser W.J. Historical development of chemical notations. J. Chem. Inform. Comput. Sci. 1985, 25:258-263.
23. Stein, S. E., Heller, S. R., Tchekhovski, D. An open standard for chemical structure representation: the IUPAC chemical identifier. Proceedings of the 2003 International Chemical Information Conference (Nimes, France), Infonortics, 2003, pp. 131-143.
24. SMARTS, a language created for matching substructures of chemical files created by Daylight Chemical Information Systems, Inc. alongside the SMILES format.
25. Tanimoto, T. T. IBM Internal Report November 17 1957.
26. Elsevier MDL, 2440 Camino Ramon, Suite 300, San Ramon, CA 94583, USA. http://www.mdl.com.
27. Durant J.L., Leland B.A., Henry D.R., Nourse J.G. Reoptimization of MDL keys for use in drug discovery. J. Chem. Inform. Comput. Sci. 2002, 42:1273-1280.
28. Daylight Chemical Information Systems, Inc, 7401 Los Altos, Suite 360, Mission Viejo, CA 92691, USA. http://www.daylight.com.
29. Wiener H. Structural determination of paraffin boiling points. J. Am. Chem. Soc. 1947, 69:17-20.
30. Wiener H. Correlation of heat of isomerization, and differences in heats of vaporization of isomers, among the paraffin hydrocarbons. J. Am. Chem. Soc. 1947, 69:2636-2638.
31. Wiener H. Influence of interatomic forces of paraffin boiling points. J. Chem. Phys. 1947, 15:766.
32. Randic M. On characterization of molecular branching. J. Am. Chem. Soc. 1975, 97:6609-6615.
33. Kier L.B., Hall L.H. The nature of structure-activity relationships and their relation to molecular connectivity. Eur. J. Med. Chem. 1977, 12:307-312.
34. Kier L.B., Hall L.H. An electrotopological-state index for atoms in molecules. Pharmaceut. Res. 1990, 7:801-807.
35. Burden F.R. Molecular identification numbers for substructure searches. J. Chem. Inform. Comput. Sci. 1989, 29:225-228.
36. Gálvez J., Garcia R., Salabert M.T., Soler R. Charge indexes. New topological descriptors. J. Chem. Inform. Comput. Sci. 1994, 34:520-525.
37. Estrada E., Uriarte E. Recent advances on the role of topological indices in drug discovery. Curr. Med. Chem. 2001, 8:1573-1588.
38. Hopkinson G.A. Structure and substructure searching. Encyclopedia of Computational Chemistry 1998, Vol. 4:2764-2771. John Wiley, New York. P. Von Ragué Schleyer, N.L. Allinger, T. Clark, J. Gasteiger, P.A. Kollman, H.F. Schaefer, P.R. Schreiner (Eds.).
39. Bron C., Kerbosch J.A.G.M. Algorithm 457: Finding all cliques of an undirected graph. Commun. ACM 1973, 16:575-577.
40. Carraghan R., Pardalos P.M. An exact algorithm for the maximum clique problem. Oper. Res. Lett. 1990, 9:375-382.
41. Rarey M., Dixon J.S. Feature trees: a new molecular similarity measure based on tree matching. J. Comput.-Aided Mol. Des. 1998, 12:471-490.
42. Rarey M., Fricker P., Hindle S., Metz G., Rummey C., Zimmermann M. Feature trees: theory and applications from large-scale virtual screening to data analysis. Pharmacophores and Pharmacophore Searches 2006, 81-116. Wiley-VCH, Weinheim. T. Langer, R.D. Hoffmann (Eds.).
43. FlexX as well as FTrees are available from BioSolveIT GmbH, An der Ziegelei 75, 53757 Sankt Augustin, Germany (). http://www.biosolveit.com.
44. Baringhaus K.-H., Hessler G. Fast similarity searching and screening hit analysis. Drug Discov. Today Technol. 2004, 1:197-202.
45. Lengauer T., Lemmen C., Rarey M., Zimmermann M. Novel technologies for virtual screening. Drug Discov. Today 2004, 9:27-34.
46. Briem H., Lessel U.F. In vitro and in silico affinity fingerprints: finding similarities beyond structural classes. Perspect. Drug Discov. Des. 2000, 20:231-244.
47. Zupan J., Gasteiger J. Neural Networks in Chemistry 1999, Wiley-VCH, Weinheim. 2nd Edition.
48. ADRIANA.Code is available from Molecular Networks GmbH, Henkestraβe 91, 91052 Erlangen, Germany (). http://www.molecular-networks.com.
49. Gasteiger J., Marsili M. Iterative partial equalization of orbital electronegativity - A rapid access to atomic charges. Tetrahedron 1980, 36:3219-3228.
50. Gasteiger J., Hutchings M.G. Quantification of effective polarisability. Applications to studies of X-ray photoelectron spectroscopy and alkylamine protonation. J. Chem. Soc. Perkin. 1984, 2:559-564.
51. The CSD is available from the Cambridge Crystallographic Data Center, 12 Union Road, Cambridge, CB2 1EZ, UK (). http://www.ccdc.cam.uk.
52. Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., Shindyalov I.N., Bourne P.E. The protein data bank. Nucleic Acids Res. 2000, 28:235-242. The Protein Database is available on the web (http://www.rcsb.org/pdb).
53. Chemical Abstract Services, 2540 Olentangy River Road, PO Box 3012, Columbus, OH 43202, USA. (). http://www.cas.org/cgi-bin/cas/regreport.pl.
54. Sadowski J. Three-dimensional structure generation: automation. Encyclopedia of Computational Chemistry 1998, Vol. 5:2976-2988. John Wiley, New York. P. Von Ragué Schleyer, N.L. Allinger, T. Clark, J. Gasteiger, P.A. Kollman, H.F. Schaefer, P.R. Schreiner (Eds.).
55. Sadowski J., Gasteiger J. From atoms to bonds to three-dimensional atomic coordinates: automatic model builders. Chem. Rev. 1993, 93:2567-2581.
56. Sadowski J., Gasteiger J., Klebe G. Comparison of automatic three-dimensional model builders using 639 X-ray structures. J. Chem. Inform. Comput. Sci. 1994, 34:1000-1008.
57. Gasteiger J., Rudolph C., Sadowski J. Automatic generation of 3D-atomic coordinates for organic molecules. Tetrahedron Comput. Meth. 1990, 3:537-547.
58. CORINA is available from Molecular Networks GmbH, Henkestraβe 91, 91052 Erlangen, Germany (). http://www.molecular-networks.com.
59. Pearlman R.S. Rapid generation of high quality approximate 3D molecular structures. Chem. Des. Autom. News 1987, 2:1-7.
60. Pearlman R.S. 3D molecular structures: generation and use in 3D-searching. 3D QSAR in Drug Design: Theory, Methods, and Applications 1993, 21-58. ESCOM Science Publishers, Leiden. H. Kubinyi (Ed.).
61. CONCORD is available from Tripos, 1699 South Hanley Road, St. Louis, MO 63144-2319, USA (). http://www.tripos.com.
62. OMEGA is available from OpenEye Scientific Software, 9 Bisbee Court, Suite D Santa Fe, NM 87508, USA (). http://www.eyesopen.com.
63. CATALYST is available from Accelrys, Inc. 10188 Telesis Court, Suite 100 San Diego, CA 92121, USA (). http://www.accelrys.com.
64. Boström J. Reproducing the conformations of protein-bound ligands: a critical evaluation of several popular conformational searching tools. J. Comput.-Aided Mol. Des. 2001, 15:1137-1152.
65. Boström J., Greenwood J.R., Gottfries J. Assessing the performance of OMEGA with respect to retrieving bioactive conformations. J. Mol. Graph. Model. 2003, 21:449-462.
66. Kirchmair J., Laggner C., Wolber G., Langer T. Comparative analysis of protein-bound ligand conformations with respect to catalyst's conformational space subsampling algorithms. J. Chem. Inform. Model. 2005, 45:422-430.
67. Kirchmair J., Wolber G., Laggner C., Langer T. Comparative performance assessment of the conformational model generators omega and catalyst: a large-scale survey on the retrieval of protein-bound ligand conformations. J. Chem. Inform. Model. 2006, 46:1848-1861.
68. Leach A.R. A survey of methods for searching the conformational space of small and medium-sized molecules. Reviews in Computational Chemistry 1991, Vol. 2:1-55. VCH Verlagsgesellschaft, New York. K.B. Lipkowitz, D.B. Boyd (Eds.).
69. Saunders M. Stochastic exploration of molecular mechanics energy surfaces. Hunting for the global minimum. J. Am. Chem. Soc. 1987, 109:3150-3152.
70. Saunders M. Stochastic search for the conformations of bicyclic hydrocarbons. J. Comput. Chem. 1989, 10:203-208.
71. McGarrah D.B., Judson R.S. Analysis of the genetic algorithm method of molecular conformation determination. J. Comput. Chem. 1993, 14:1385-1395.
72. Judson R.S., Jaeger E.P., Treasurywala A.M., Peterson M.L. Conformational searching methods. II. Genetic algorithm approach. J. Comput. Chem. 1993, 14:1407-1414.
73. Lybrand T.P. Computer simulations of biomolecular systems using molecular dynamics and free energy perturbation methods. Reviews in Computational Chemistry 1990, Vol. 1:295-320. VCH Verlagsgesellschaft, New York. K.B. Lipkowitz, D.B. Boyd (Eds.).
74. Chang G., Guida W.C., Still W.C. An internal coordinate Monte Carlo method for searching conformational space. J. Am. Chem. Soc. 1989, 111:4379-4386.
75. Schönberger H., Schwab C.H., Hirsch A., Gasteiger J. Molecular modelling of fullerene dendrimers. J. Mol. Model. 2000, 6:379-395.
76. ROTATE is available from Molecular Networks GmbH, Henkestraβe 91, 91052 Erlangen, Germany (). http://www.molecular-networks.com.
77. Li J., Ehlers T., Sutter J., Varma-O'Brien S., Kirchmair J. CAESAR: a new conformer generation algorithm based on recursive buildup and local rotational symmetry consideration. J. Chem. Inform. Model. 2007, ASAP Article 10.1021/ci700136x S1549-9596(70)00136-5 Web Release August 11, 2007.
78. Wagener M., Sadowski J., Gasteiger J. Autocorrelation of molecular surface properties for modelling corticosteroid binding globulin and cytosolic Ah receptor activity by neural networks. J. Am. Chem. Soc. 1995, 117:7769-7775.
79. Soltzberg L.J., Wilkins C.L. Molecular transforms: a potential tool for structure-activity studies. J. Am. Chem. Soc. 1977, 99:439-443.
80. Schuur J.H., Selzer P., Gasteiger J. The coding of the three-dimensional structure of molecules by molecular transforms and its applications to structure-spectra correlations and studies of biological activity. J. Chem. Inform. Comput. Sci. 1996, 36:334-344.
81. Gasteiger J., Schuur J., Selzer P., Steinhauer L., Steinhauer V. Finding the 3D structure of a molecule in its IR spectrum. Fresen. J. Anal. Chem. 1997, 359:50-55.
82. Hemmer M.C., Steinhauer V., Gasteiger J. Deriving the 3D structure of organic molecules from their infrared spectra. Vibrat. Spectrosc. 1999, 19:151-154.
83. Wermuth C.-G., Ganellin C.R., Lindberg P., Mitscher L.A. Glossary of terms used in medicinal chemistry (IUPAC recommendations 1997). Annu. Rep. Med. Chem. 1998, 33:385-395.
84. Kurogi Y., Güner O.F. Pharmacophore modeling and three-dimensional database searching for drug design using catalyst. Curr. Med. Chem. 2001, 8:1035-1055.
85. Langer T., Krovat E.-M. Chemical feature-based pharmacophores and virtual library screening for discovery of new leads. Curr. Opin. Drug Discov. Dev. 2003, 6:370-376.
86. Langer T., Hoffmann R.D. Pharmacophore modeling: applications in drug discovery. Exp. Opin. Drug Discov. 2006, 1:261-267.
87. Manetti F., Botta M., Tafi A. Application of pharmacophore models in medicinal chemistry. Pharmacophores and Pharmacophore Searches 2006, 253-282. Wiley-VCH, Weinheim. T. Langer, R.D. Hoffmann (Eds.).
88. Dixon S.L., Smondyrev A.M., Rao S.R. PHASE: a novel approach to pharmacophore modeling and 3D database searching. Chem. Biol. Drug Des. 2006, 67:370-372.
89. PHASE is available from Schrödinger Inc., 120 W. 45th St, 29th Floor, New York, NY 10036, USA (). http://www.schrodinger.com.
90. MOE is available from the Chemical Computing Group, Suite 910-1010 Sherbrooke St. W, Montreal, Canada H3A 2R7 (). http://www.chemcomp.com.
91. Richmond N.J., Willett P., Clark R.D. Alignment of three-dimensional molecules using an image recognition algorithm. J. Mol. Graph. Model. 2004, 23:199-209.
92. Cottrell S.J., Gillet V.J., Taylor R., Wilton D.J. Generation of multiple pharmacophore hypotheses using multiobjective optimisation techniques. J. Comput.-Aided Mol. Des. 2004, 18:665-682.
93. GALAHAD is available from Tripos, 1699 South Hanley Road, St. Louis, MO 63144-2319, USA (). http://www.tripos.com.
94. Wolber G., Langer T. LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J. Chem. Inform. Model. 2005, 45:160-169.
95. LIGANDSCOUT is available from Inte:Ligand GmbH, Mariahilferstrasse 74b/11, 1070 Vienna, Austria (). http://www.inteligand.com.
96. Bramson H.N., Corona J., Davis S.T., Dickerson S.H., Edelstein M., Frye S.V., Gampe R.T., Harris P.A., Hassell A., Holmes W.D., Hunter R.N., Lackey K.E., Lovejoy B., Luzzio M.J., Montana V., Rocque W.J., Rusnak D., Shewchuk L., Veal J.M., Walker D.H., Kuyper L.F. Oxindole-based inhibitors of cyclin-dependent kinase 2 (CDK2): design, synthesis, enzymatic activities, and X-ray crystallographic analysis. J. Med. Chem. 2001, 44:4339-4358.
97. Goodford P.J. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J. Med. Chem. 1985, 28:849-857.
98. Cramer R.D., Patterson D.E., Bunce J.D. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc. 1988, 110:5959-5967.
99. Wold S., Ruhe A., Wold H., Dunn W.J. The covariance problem in linear regression. The partial least squares (PLS) approach to generalized inverses. SIAM J. Sci. Stat. Comput. 1984, 5:735-743.
100. Pearlman R.S., Smith K.M. Novel software tools for chemical diversity. Perspect. Drug Discov. Des. 1998, 9:339-353.
101. Pearlman R.S., Smith K.M.J. Metric validation and the receptor-relevant subspace concept. J. Chem. Inform. Comput. Sci. 1999, 39:28-35.
102. Ferguson A.M., Heritage T.W., Jonathon P., Pack S.E., Phillips L., Rogan J., Snaith P.J. EVA: a new theoretically based molecular descriptor for use in QSAR/QSPR analysis. J. Comput.-Aided Mol. Des. 1997, 11:143-152.
103. Turner D.B., Willet P., Ferguson A.M., Heritage T.W. Evaluation of a novel infrared range vibration-based descriptor (EVA) for QSAR studies. 1. General applications. J. Comput.-Aided Mol. Des. 1997, 11:409-422.
104. Todeschini R., Lasagni M., Marengo E. New molecular descriptors for 2D- and 3D-structures. Theory. J. Chemo. 1994, 8:263-273.
105. Todeschini R., Gramatica P. 3D-modelling and prediction by WHIM descriptors. Part 5. Theory development and chemical meaning of WHIM descriptors. Quant. Struct.-Act. Relat. 1997, 16:113-119.
106. Todeschini R., Consonni V. The handbook to molecular descriptors. Methods and Principles in Medicinal Chemistry 2000, Vol. 11. Wiley-VCH, Weinheim. R. Mannhold, H. Kubinyi, H. Timmermann (Eds.).
107. Xue L., Bajorath J. Molecular descriptors in chemoinformatics, computational combinatorial chemistry, and virtual screening. Combin. Chem. High Throughput Screening 2000, 3:363-372.
108. Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 1997, 23:3-25.
109. Clark D.E., Pickett S.D. Computational methods for the prediction of 'drug-likeness'. Drug Discov. Today 2000, 5:49-58.
110. Ajay A., Walters W.P., Murcko M.A. Can we learn to distinguish between 'drug-like' and 'non drug-like' molecules?. J. Med. Chem. 1998, 41:3314-3324.
111. Blake J.F. Chemoinformatics - predicting the physicochemical properties of 'drug-like' molecules. Curr. Opin. Biotechnol. 2000, 11:104-107.
112. Teague S.J., Davis A.M., Leeson P.D., Oprea T. The design of leadlike combinatorial libraries. Angew. Chem. Int. Ed. Engl. 1999, 38:3743-3747.
113. Oprea T.I., Davis A.M., Teague S.J., Leeson P.D. Is there a difference between leads and drugs? A historical perspective. J. Chem. Inform. Comput. Sci. 2001, 41:1308-1315.
114. Li A.P., Segall M. Early ADME/Tox studies and in silico screening. Drug Discov. Today 2002, 7:25-27.
115. Li A.P. Screening for human ADME/Tox drug properties in drug discovery. Drug Discov. Today 2001, 6:357-366.
116. Thompson T.N. Early ADME in support of drug discovery: the role of metabolic stability studies. Curr. Drug Metabol. 2000, 1:215-241.
117. Keserü G.M., Molnár L. METAPRINT: a metabolic fingerprint. Application to cassette design for high-throughput ADME screening. J. Chem. Inform. Comput. Sci. 2002, 42:437-444.
118. Andrews P.R., Craik D.J., Martin J.L. Functional group contributions to drug-receptor interactions. J. Med. Chem. 1984, 27:1648-1657.
119. The Beilstein Crossfire database is available from Elsevier MDL, 2440 Camino Ramon, Suite 300, San Ramon, CA 94583, USA (). http://www.mdl.com.
120. The PubChem database contains more than 10M chemical structures and is publicly available on the web (). http://www.pubchem.ncbi.nlm.nih.gov.
121. Willet P., Barnard J.M., Downs M. Chemical similarity searching. J. Chem. Inform. Comput. Sci. 1998, 38:983-996.
122. Agrafiotis D.K. Diversity of chemical libraries. Encyclopedia of Computational Chemistry 1998, Vol. 1:742-761. John Wiley, New York. P. Von Ragué Schleyer, N.L. Allinger, T. Clark, J. Gasteiger, P.A. Kollman, H.F. Schaefer, P.R. Schreiner (Eds.).
123. Agrafiotis D.K. Multiobjective optimization of combinatorial libraries. IBM J. Res. Dev. 2001, 45:545-566.
124. Lewis R.A., Pickett S.D., Clark D.E. Computer-aided molecular diversity analysis and combinatorial library design. Reviews in Computational Chemistry 2000, Vol. 16:1-51. Wiley-VCH, New York. D.B. Lipkowitz, D.B. Boyd (Eds.).
125. Warr W.A. Combinatorial chemistry and molecular diversity. An overview. J. Chem. Inform. Comput. Sci. 1997, 37:134-140.
126. Blaney J.M., Martin E.J. Computational approaches for combinatorial library design and molecular diversity analysis. Curr. Opin. Chem. Biol. 1997, 1:54-59.
127. Hopkinson G.A. Structure and substructure searching. Encyclopedia of Computational Chemistry 1998, Vol. 4:2764-2771. John Wiley, New York. P. Von Ragué Schleyer, N.L. Allinger, T. Clark, J. Gasteiger, P.A. Kollman, H.F. Schaefer, P.R. Schreiner (Eds.).
128. Willet P. Similarity and clustering techniques in chemical information systems. Chemometric Series 1987, Vol. 18:1-254. Research Studies Press, Letchworth, UK. D. Bawden (Ed.).
129. Willet P. Structural similarity measures for database setting. Encyclopedia of Computational Chemistry 1998, Vol. 4:2748-2756. John Wiley, New York. P. Von Ragué Schleyer, N.L. Allinger, T. Clark, J. Gasteiger, P.A. Kollman, H.F. Schaefer, P.R. Schreiner (Eds.).
130. Willet P. Chemoinformatics - similarity and diversity in chemical libraries. Curr. Opin. Biotechnol. 2000, 11:85-88.
131. Hoffmann R.D., Meddeb S., Langer T. Use of 3D pharmacophore models in 3D database searching. Computational Medicinal Chemistry and Drug Discovery 2003, 461-482. Dekker, Inc., New York. J. Tollenaere, H. De Winter, W. Langenaeker, P. Bultinck (Eds.).
132. Güner O.F., Hughes D.W., Dumont L.M. An integrated approach to three-dimensional information management with MACCS-3D. J. Chem. Inform. Comput. Sci. 19991, 31:408-414.
133. Wolber G., Dornhofer A.A., Langer T. Efficient overlay of small organic molecules using 3D pharmacophores. J. Comput.-Aided Mol. Des. 2006, 20:773-788.
134. GünerO.F. (Ed.). Pharmacophore Perception, Development, and Use in Drug Design 2000, International University Line, La Jolla, CA.
135. Langer T., Hoffmann R.D. Pharmacophores and pharmacophore searches. Methods and Principles in Medicinal Chemistry 2006, Vol. 32. Wiley-VCH, Weinheim. R. Mannhold, H. Kubinyi, G. Folkers (Eds.).
136. Kuntz I.D., Blaney J.M., Oatley S.J., Langridge R., Ferrin T.E. A geometric approach to macromolecule-ligand interactions. J. Mol. Biol. 1982, 161:269-288.
137. Jones G., Willet P. Docking small-molecules ligands into active sites. Curr. Opin. Biotechnol. 1995, 6:652-656.
138. Jones G., Willet P., Glen R.C., Leach A.R., Taylor R. Development and validation of a genetic algorithm for flexible docking. J. Mol. Biol. 1997, 267:727-748.
139. Shoichet B.K., Bodian D.L., Kuntz I.D. Molecular docking using shape descriptors. J. Comput. Chem. 1992, 13:380-397.
140. Meng E.C., Shoichet B.K., Kuntz I.D. Automated docking with grid-based energy evaluation. J. Comput. Chem. 1992, 13:505-524.
141. Sun Y., Ewing T.J.A., Skilman A.G., Kuntz I.D. CombiDOCK: structure-based combinatorial docking and library design. J. Comput.-Aided Mol. Des. 1998, 20:773-788.
142. Rarey M., Kramer B., Lengauer T., Klebe G. A fast flexible docking method using an incremental construction algorithm. J. Mol. Biol. 1996, 261:470-489.
143. Rarey M., Kramer B., Lengauer T. Multiple automatic base selection: protein-ligand docking based on incremental construction without manual intervention. J. Comput.-Aided Mol. Des. 1997, 11:369-384.
144. Yang J.-M., Kao C.-Y. Flexible ligand docking using a robust evolutionary algorithm. J. Comput. Chem. 2000, 21:988-998.
145. Morris G.M., Goodsell D.S., Halliday R.S., Huey R., Hart W.E., Belew R.K., Olson A.J. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 1998, 19:1639-1662.
146. Steindl T.M., Langer T. Docking versus pharmacophore model generation: a comparison of high-throughput virtual screening strategies for the search of human rhinovirus coat protein inhibitors. QSAR Combin. Sci. 2005, 24:470-479.
147. Krovat E.-M., Steindl T., Langer T. Recent advances in docking and scoring. Curr. Comput.-Aided Drug Des. 2005, 1:93-102.
148. Warren G.L., Andrews C.W., Capelli A.-M., Clarke b., LaLonde J., Lambert M.H., Lindvall M., Nevins N., Semus S.F., Senger S., Tedesco G., Wall I.D., Woolven J.M., Peishoff C.E., Head M.S. A critical assessment of docking programs and scoring functions. J. Med. Chem. 2006, 49:5912-5931.
149. Bauknecht H., Zell A., Bayer H., Levi P., Wagener M., Sadowski J., Gasteiger J. Locating biologically active compounds in medium-sized heterogeneous datasets by topological autocorrelation vectors: dopamine and benzodiazepine antagonists. J. Chem. Inform. Comput. Sci. 1996, 36:1205-1213.
150. Sadowski J., Wagener M., Gasteiger J. Assessing similarity and diversity of combinatorial libraries by special autocorrelation function and neural networks. Angew. Chem. Int. Ed. Engl. 1995, 24:2674-2677.
151. Teckentrup A., Briem H., Gasteiger J. Mining high-throughput screening data of combinatorial libraries: development of a filter to distinguish hits from nonhits. J. Chem. Inform. Comput. Sci. 2004, 44:626-634.
152. Mestres J., Veeneman G.H. Identification of 'latent hits' in compound screening collections. J. Med. Chem. 2003, 46:3441-3444.
153. Sprague P.W. Automated chemical hypothesis generation and database searching with Catalyst. Perspect. Drug Discov. Des. 1995, 3:1-20.
154. Barnum D., Greene J., Smellie A., Sprague P.W. Identification of common functional configurations among molecules. J. Chem. Inform. Comput. Sci. 1996, 36:563-571.
155. Sprague P.W., Hoffman R. CATALYST pharmacophore models and their utility as queries for searching 3D databases. Computer-Assisted Lead Finding and Optimization 1997, 225-240. Verlag Helvetica Chimica Acta, Basel. H. Van de Waterbeemd, B. Testa, G. Folkers (Eds.).
156. Wang S., Zaharevitz D.W., Sharma R., Marquez V.E., Lewin N.E., Du L., Blumberg P.M., Milne G.W.A. The discovery of novel, structurally diverse protein kinase C agonists through computer 3D-database pharmacophore search. Molecular modeling studies. J. Med. Chem. 1994, 37:4479-4489.
157. Kaminski J.J., Rane D.F., Snow M.E., Weber L., Rothofsky M.L., Anderson S.D. Lin SL Identification of novel farnesyl protein transferase inhibitors using three-dimensional searching methods. J. Med. Chem. 1997, 40:4103-4112.
158. Nicklaus M.C., Neamati N., Hong H., Mazumder A., Sunder S., Chen J., Milne G.W.A., Pommier Y. HIV-1 integrase pharmacophore: discovery of inhibitors through three-dimensional database searching. J. Med. Chem. 1997, 40:920-929.
159. Carlson H.A., Masukawa K.M., Rubins K., Bushman F.D., Jorgenson W.L., Lins R.D., Briggs J.M., McCammon J.A. Developing a dynamic pharmacophore model for HIV-1 integrase. J. Med. Chem. 2000, 43:2100-2114.
160. Koide Y., Hasegawa T., Takahashi A., Endo A., Mochizuki N., Nakagawa M., Nishida A. Development of novel EDG3 antagonists using a 3D database search and their structure-activity relationships. J. Med. Chem. 2002, 45:4629-4638.
161. Flohr S., Kurz M., Kostenis E., Brkovich A., Fournier A., Klabunde T. Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II. J. Med. Chem. 2002, 45:1799-1805.
162. Debnath A.K. Generation of predictive pharmacophore models for CCR5 antagonists: study with piperidine- and piperazine-based compounds as a new class of HIV-1 entry inhibitors. J. Med. Chem. 2003, 46:4501-4515.
163. Kurogi Y., Miyata K., Okamura T., Hashimoto K., Tsutsumi K., Nasu M., Moriyasu M. Discovery of novel mesangial cell proliferation inhibitors using a three-dimensional database searching method. J. Med. Chem. 2001, 44:2304-2307.
164. Funk O.F., Kettmann V., Drimal J., Langer T. Chemical function based pharmacophore generation of endothelin-A selective receptor antagonists. J. Med. Chem. 2004, 47:2750-2760.
165. Laggner C., Schieferer C., Fiechtner B., Poles G., Hoffmann R.D., Glossmann H., Langer T., Moebius F.F. Discovery of high-affinity ligands of sigma-1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening. J. Med. Chem. 2004, 48:4754-4764.
166. Ekins S., Swaan P.W. Development of computational models for enzymes, transporters, channels and receptors relevant to ADME/TOX. Rev. Comput. Chem. 2004, 20:333-415.
167. Klebe, G. (Ed.) Virtual screening: an alternative or complement to high throughput screening, Perspect. Drug Discov. Des. 2000, 20, 1-187.
168. Bissantz C., Folkers G., Rognan D. Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. J. Med. Chem. 2000, 43:4759-4767.
169. Böhm H.-J., Schneider G. Virtual screening for bioactive molecules. Methods and Principles in Medicinal Chemistry 2000, Vol. 10:1-307. Wiley-VCH, Weinheim. R. Mannhold, H. Kubinyi, H. Timmermann (Eds.).
170. Krier M., de Araujo-Junior J.X., Schmitt M., Duranton J., Justiano-Basaran H., Lugnier C., Bourguignon J.-J., Rognan D. Design of small-sized libraries by combinatorial assembly of linkers and functional groups to a given scaffold: application to the structure-based optimization of a phosphodiesterase 4 inhibitor. J. Med. Chem. 2005, 48:3816-3822.
171. Barreca M.L., De Luca L., Iraci N., Rao A., Ferro S., Maga G., Chimirri A. Structure-based pharmacophore identification of new chemical scaffolds as non-nucleoside reverse transcriptase inhibitors. J. Chem. Inform. Model. 2007, 47:557-562.
172. Rollinger J.M., Hornick A., Langer T., Stuppner H., Prast H. Acetylcholinesterase inhibitory activity of scopolin and scopoletin discovered by virtual screening of natural products. J. Med. Chem. 2004, 47:6248-6254.
173. Wang S., Sakamuri S., Enyedy I.J., Kozikowski A.P., Deschaux O., Bandyopadhyay B.C., Tella S.R., Zaman W.A., Johnson K.M. Discovery of a novel dopamine transporter inhibitor, 4-hydroxy-1-methyl-4-(4-methylphenyl)-3-piperidyl 4-methylphenyl ketone, as a potential cocaine antagonist through 3D-database pharmacophore searching. Molecular modeling, structure-activity relationships, and behavioral pharmacological studies. J. Med. Chem. 2000, 43:351-360.
174. Aronov A.M., Munagala N.R., Ortiz de Montellano P.R., Kuntz I.D., Wang C. Rational design of selective submicromolar Tritrichomonas foetus hypoxanthine-guanine-xanthine phosphoribosyltransferase. Biochemistry 2000, 39:4684-4691.
175. Sarmiento M., Wu L., Keng Y.-F., Song L., Luo Z., Huang Z., Wu G.-Z., Yuan A.K., Zhang Z.-Y. Structure-based discovery of small molecule inhibitors targeted to protein tyrosine phosphatase 1B. J. Med. Chem. 2000, 43:146-155.
176. Zhao L., Brinton R.D. Structure-based virtual screening for plant-based ER-selective ligands as potential preventative therapy against age-related neurodegenerative diseases. J. Med. Chem. 2005, 48:3463-3466.
177. Rella M., Rushworth C.A., Guy J.L., Turner A.J., Langer T., Jackson R.M. Structure-based pharmacophore design and virtual screening for novel angiotensin converting enzyme 2 inhibitors. J. Chem. Inform. Model. 2006, 46:708-716.
178. Steindl T., Langer T. Influenza virus neuraminidase inhibitors: generation and comparison of structure-based and common feature pharmacophore hypotheses and their application in virtual screening. J. Chem. Inform. Comput. Sci. 2004, 44:1849-1856.
179. Lu I.L., Huang C.-F., Peng Y.-F., Lin Y.-T., Hsieh H.-P., Chen C.-T., Lien T.-W., Lee H.-J., Mahindroo N., Prakash E., Yueh A., Chen H.-Y., Goparaju C.M.V., Chen X., Liao C.-C., Chao Y.-S., Hsu J.T.-A., Wu S.-Y. Structure-based drug design of a novel family of PPAR partial agonists: virtual screening, X-ray crystallography, and in vitro/in vivo biological activities. J. Med. Chem. 2006, 49:2703-2712.
180. Ward R.A., Perkins T.D.J., Stafford J. Structure-based virtual screening for low molecular weight chemical starting points for dipeptidyl peptidase IV inhibitors. J. Med. Chem. 2005, 48:6991-6996.
181. Zhang Q.Y., Wan J., Xu X., Yang G.F., Ren Y.L., Liu J.J., Wang H., Guo Y. Structure-based rational quest for potential novel inhibitors of human HMG-CoA reductase by combining CoMFA 3D QSAR modeling and virtual screening. J. Combin. Chem. 2007, 9:131-138.
182. Evers A., Klabunde T. Structure-based drug discovery using GPCR homology modeling: successful virtual screening for antagonists of the alpha1A adrenergic receptor. J. Med. Chem. 2005, 48:1088-1097.
183. Triballeau N., Acher F., Brabet I., Pin J.-P., Bertrand H.-O. Virtual screening workflow development guided by the "receiver operating characteristic" curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4. J. Med. Chem. 2005, 48:2534-2547.
184. Ekins S., Mestres J., Testa B. In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling. Br. J. Pharmacol. 2007, 152:9-20.
185. Ekins S., Mestres J., Testa B. In silico pharmacology for drug discovery: applications to targets and beyond. Br. J. Pharmacol. 2007, 152:21-37.
186. Rognan D. Chemogenomic approaches to rational drug design. Br. J. Pharmacol. 2007, 152:38-52.
187. Poroikov V.V., Filimonov D.A., Borodina Y.V., Lagunin A.A., Kos A. Robustness of biological activity spectra predicting by computer program PASS for noncongeneric sets of chemical compounds. J. Chem. Inform. Comput. Sci. 2000, 40:1349-1355.
188. Poulain R., Horvath D., Bonnet B., Eckhoff C., Chapelain B., Bodinier M.C., Déprez B. From hit to lead. Analyzing structure-profile relationships. J. Med. Chem. 2001, 44:3391-3401.
189. Fliri A.F., Loging W.T., Thadeio P.F., Volkmann R.A. Biospectra analysis: model proteome characterizations for linking molecular structure and biological response. J. Med. Chem. 2005, 48:6918-6925.
190. Schuffenhauer A., Zimmermann J., Stoop R., van der Vyver J.J., Lecchini S., Jacoby E. An ontology for pharmaceutical ligands and its application for in silico screening and library design. J. Chem. Inform. Comput. Sci. 2002, 42:947-955.
191. Schuffenhauer A., Jacoby E. Annotating and mining the ligand-target chemogenomics knowledge space. Drug Discov. Today Biosilico 2004, 2:190-200.
192. Steindl T.M., Schuster D., Laggner C., Langer T. Parallel Screening: a novel concept in pharmacophore modeling and virtual screening. J. Chem. Inform. Model. 2006, 46:2146-2157.
193. Steindl T.M., Schuster D., Wolber G., Laggner C., Langer T. High-throughput structure-based pharmacophore modelling as a basis for successful parallel virtual screening. J. Comput.-Aided Mol. Des. 2006, 20:703-715.
194. Steindl T.M., Schuster D., Laggner C., Chuang K., Hoffmann R.D., Langer T. Parallel screening and activity profiling with HIV protease inhibitor pharmacophore models. J. Chem. Inform. Model. 2007, 47:563-571.
195. Stahura F.L., Bajorath J. Virtual screening methods that complement HTS. Combin. Chem. High Throughput Screening 2004, 7:259-269.
196. Klebe G. Virtual ligand screening: strategies, perspectives and limitations. Drug. Discov. Today 2006, 11:580-594.
197. Bajorath J. Integration of virtual and high-throughput screening. Nat. Rev. Drug Discov. 2002, 1:882-894.
198. Shoichet B.K. Virtual screening of chemical libraries. Nature 2004, 432:862-865.
199. Bleicher K.H., Böhm H.-J., Müller K., Alanine A.I. Hit and lead generation: beyond high-throughput screening. Nat. Rev. Drug Discov. 2003, 2:369-378.
200. Zhang Q., Muegge I. Scaffold hopping through virtual screening using 2D and 3D similarity descriptors: ranking, voting, and consensus scoring. J. Med. Chem. 2006, 49:1536-1548.
201. Paolini G.V., Shapland R.H., van Hoorn W.P., Mason J.S., Hopkins A.L. Global mapping of pharmacological space. Nat. Biotechnol. 2006, 24:805-815.
202. Mestres J. Computational chemogenomics approaches to systematic knowledge-based drug discovery. Curr. Opin. Drug Discov. Dev. 2004, 7:304-313.
203. Wermuth C.-G. The "Sosa" approach: an alternative to high-throughput screening. Med. Chem. Res. 2001, 10:431-439.
204. Moreau G. Autocorrelation of molecular strucutres: Application to SAR studies. Nouv. J. Chem. 1980, 4:757-764.